Could a common diabetes drug protect the hearts of kidney patients?
Disease control
Terminated
People with chronic kidney disease (CKD) often have an overactive sympathetic nervous system, which raises their risk of heart problems and death. This phase 4 trial tests whether pioglitazone, a drug usually used for diabetes, can reduce that nerve overactivity and improve blood…
Phase: PHASE4 • Sponsor: The University of Texas at Arlington • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC